| Epigenetic and breast cancer therapy: promising diagnostic and therapeutic applications G Sher, NA Salman, AQ Khan, KS Prabhu, A Raza, M Kulinski, ... Seminars in cancer biology 83, 152-165, 2022 | 55 | 2022 |
| Dysregulated FOXM1 Signaling in the regulation of cancer stem cells G Sher, T Masoodi, K Patil, S Akhtar, S Kuttikrishnan, A Ahmad, S Uddin Seminars in Cancer Biology, 2022 | 45 | 2022 |
| Prevalence and Type Distribution of High-Risk Human Papillomavirus (HPV) in Breast Cancer: A Qatar Based Study G Sher, NA Salman, M Kulinski, RA Fadel, VK Gupta, A Anand, S Gehani, ... Cancers 12 (6), 1528, 2020 | 27 | 2020 |
| Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases AQ Khan, F Ahmad, SS Raza, L Zarif, KS Siveen, G Sher, MV Agha, ... Seminars in Cancer Biology 83, 208-226, 2022 | 21 | 2022 |
| A novel CHSY1 gene mutation underlies Temtamy preaxial brachydactyly syndrome in a Pakistani family G Sher, M Naeem European journal of medical genetics 57 (1), 21-24, 2014 | 19 | 2014 |
| The effect of protein mutations on drug binding suggests ensuing personalised drug selection S Wan, D Kumar, V Ilyin, U Al Homsi, G Sher, A Knuth, PV Coveney Scientific Reports 11 (1), 1-10, 2021 | 12 | 2021 |
| Outcome associated with EPCAM founder mutation c. 499dup in Qatar K Hassan, G Sher, E Hamid, K Abou Hazima, H Abdelrahman, ... European Journal of Medical Genetics 63 (10), 104023, 2020 | 7 | 2020 |
| Molecular characteristics of Neisseria meningitidis in Qatar MM Hamed, FA Mir, EBI Elmagboul, A Al-Khal, MARS Maslamani, ... Scientific reports 11 (1), 1-7, 2021 | 6 | 2021 |
| UGT1A1 gene mutations in Pakistani children suffering from inherited nonhemolytic unconjugated hyperbilirubinemias S Khan, M Irfan, G Sher, B Zubaida, MA Alvi, M Yasinzai, M Naeem Annals of human genetics 77 (6), 482-487, 2013 | 6 | 2013 |
| The cross-talk between miRNAs and JAK/STAT pathway in cutaneous T cell lymphoma: Emphasis on therapeutic opportunities K Patil, G Sher, S Kuttikrishnan, S Moton, M Alam, J Buddenkotte, ... Seminars in Cell & Developmental Biology, 2022 | 4 | 2022 |
| Bioinformatics Analysis Reveals FOXM1/BUB1B Signaling Pathway as a Key Target of Neosetophomone B in Human Leukemic Cells: A Gene Network-Based Microarray Analysis S Kuttikrishnan, T Masoodi, G Sher, AA Bhat, K Patil, T El-Elimat, ... Frontiers in Oncology 12, 2022 | 4 | 2022 |
| Genetic Testing of a Large Consanguineous Pakistani Family Affected with Mucolipidosis III Gamma Through Next-Generation Sequencing MA Khan, A Hussain, G Sher, B Zubaida, M Naeem Genetic testing and molecular biomarkers 22 (9), 541-545, 2018 | 3 | 2018 |
| From genome to personalised medicine: cancer treatment and discovery of novel variants in Qatar S Wan, D Kumar, V Ilyin, UA Homsi, G Sher, A Knuth, PV Coveney Preprint, 2020 | 2 | 2020 |
| Molecular Diagnosis of Rare Autosomal Recessive Escobar Syndrome in a Consanguineous Pakistani Family G Sher, M Naeem Genetic testing and molecular biomarkers 22 (12), 714-718, 2018 | 2 | 2018 |
| In Vitro Evaluation of Neosetophomone B Inducing Apoptosis in Cutaneous T Cell Lymphoma by Targeting the FOXM1 Signaling Pathway S Kuttikrishnan, T Masoodi, F Ahmad, G Sher, KS Prabhu, JM Mateo, ... Journal of Dermatological Science, 2023 | 1 | 2023 |
| Treatment and molecular profiling of acrodermatitis continua of Hallopeau during pregnancy using targeted therapy S Al-Khawaga, R Krishnankutty, G Sher, K Hussain, J Buddenkotte, ... JAAD case reports 16, 164-167, 2021 | 1 | 2021 |
| Beyond Viral Infections: The Multifaceted Roles of Human Papillomavirus and Epstein-Barr Virus in Shaping the Tumor Microenvironment. Q Fernandes, G Sher, KS Prabhu, S Kuttikrishnan, M Merhi, S Dermime, ... Discovery Medicine 36 (180), 1-15, 2024 | | 2024 |
| Embelin inhibits viability of cutaneous T cell lymphoma cell lines HuT78 and H9 by targeting inhibitors of apoptosis N Abdulrahman, R Leo, HA Boumenar, F Ahmad, JM Mateo, A Jochebeth, ... Leukemia & Lymphoma, 1-13, 2023 | | 2023 |
| Discovery of Novel Gene Variants in a Cohort of Qatari Breast Cancer Patients and Ensuing Personalised Drug Selection S Wan, D Kumar, V Ilyin, U Al Homsi, G Sher, KRA Knuth, P Coveney Available at SSRN 3523839, 2020 | | 2020 |
